Osman, M.M.El Taweel, H.A.Shehab, A.Y.Farag, H.F.2014-06-172014-06-172010-12-311020-3397http://applications.emro.who.int/emhj/V16/09/16_9_2010_0932_0936.pdfhttps://iris.who.int/handle/10665/117981932-936The present study assessed the schistosomicidal and fasciolicidal actions of the myrrh-derivative Mirazid in an area of low schistosomiasis transmission. A total of 27 patients infected with Schistosoma mansoni and 16 with Fasciola spp. received the maximum recommended dose of Mirazid. Pretreatment egg counts in 4 Kato-Katz slides were compared with similar counts in stool samples collected 1 and 2 months after treatment. Standard procedures and quality control measures were followed. The results revealed that Mirazid used as schistosomicidal or fasciolicidal agent in the maximum recommended dose has a low cure rate and produced a negligible reduction in egg counts. Prescribing such an ineffective drug in Egypt might endanger the achievements of the schistosomiasis control strategyenFascioliasisPlant ExtractsTreatment OutcomeSchistosomiasis mansoni